Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Healsea® Children is a seawater-based nasal spray supplemented with a natural Symbiofilm® extract (0.02%) isolated from marine bacteria. Symbiofilm has antibiofilm activity against various bacterial pathogens involved in respiratory tract infections.Healsea® Children is indicated in the cleaning and moistening of nasal mucosa during common cold and rhinitis for children above 6 years. This non interventional post-market clinical investigation aimed to confirm the benefit of Healsea® Children in real life setting in children with perennial allergy who are more prone to common cold.
Epistemonikos ID: 4e5b7ad97d18429cec37b9340e6da5bc39b345a7
First added on: May 09, 2024